Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review
Abstract Background Islet autoantibodies form the foundation for type 1 diabetes (T1D) diagnosis and staging, but heterogeneity exists in T1D development and presentation. We hypothesized that autoantibodies can identify heterogeneity before, at, and after T1D diagnosis, and in response to disease-m...
Main Authors: | Jamie L. Felton, Maria J. Redondo, Richard A. Oram, Cate Speake, S. Alice Long, Suna Onengut-Gumuscu, Stephen S. Rich, Gabriela S. F. Monaco, Arianna Harris-Kawano, Dianna Perez, Zeb Saeed, Benjamin Hoag, Rashmi Jain, Carmella Evans-Molina, Linda A. DiMeglio, Heba M. Ismail, Dana Dabelea, Randi K. Johnson, Marzhan Urazbayeva, John M. Wentworth, Kurt J. Griffin, Emily K. Sims, On behalf of the ADA/EASD PMDI |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-024-00478-y |
Similar Items
-
Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review
by: Jamie L. Felton, et al.
Published: (2023-10-01) -
4033 Evaluating the Effect of Prebiotics on the Gut Microbiome Profile and Beta-cell Function in Newly-Diagnosed Type 1 Diabetes
by: Heba M Ismail, et al.
Published: (2020-06-01) -
57437 Effects of Prebiotics on the Gut Microbiome Profile, Beta-cell Function and Immune Markers in Newly-Diagnosed Type 1 Diabetes
by: Heba M. Ismail, et al.
Published: (2021-03-01) -
Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes
by: Jeremy R. B. Newman, et al.
Published: (2023-09-01) -
Evaluating the effect of prebiotics on the gut microbiome profile and β cell function in youth with newly diagnosed type 1 diabetes: protocol of a pilot randomized controlled trial
by: Heba M. Ismail, et al.
Published: (2023-08-01)